The principal objective of this proposal is to understand the molecular mechanism of serotonin uptake by the mammalian serotonin transporter. The serotonin transporter utilizes the Na+ electrochemical potential to transpor6t neurotransmitters into the cell against their concentration gradient, so that a low extracellular neurotransmitter concentration can be maintained. The molecular mechanism that underlies this process is not known. The proposed set of experiments will help to establish an integrated picture of transporter function and identify structural domains that participate in specific steps of the transport cycle. According to this study's working hypothesis, the transporter protein contains a channel-like lumen flanked by extracellular and intracellular gates. The opening and closing of these gates is governed by the binding of organic substrate and ions in the lumen. The energetic coupling between neurotransmitter transport and the electrochemical potential of ions is a result of the sequential opening and closing of the gates as well as the dependance of neurotransmitter binding on the binding of co-transporting ions. The proposed research will utilize electrophysiology and other functional measurements in order to characterize mutated transporters, and to identify and study functional domains that contribute to specific aspects of the transport process. We will investigate domains in the protein that (1) participate in transporter gating, (2) form the transporter lumen, and (3) form and are actively involved with ion and serotonin binding sites. Studies have shown that an alterations in the activity of the human serotonin transporter is associated with several mental disorders and possibly with alcohol and cocaine abuse. The transporter is also a major target for therapeutic drugs such as fluoxetine, methylphenidate, and amphetamine. Understanding the roles of the serotonin transporter in normal brain function, mental disorders, and drug abuse requires more insight into the biophysical and molecular mechanisms of transporter function.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA012408-03
Application #
6469235
Study Section
Project Start
2001-07-01
Project End
2002-06-30
Budget Start
Budget End
Support Year
3
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Mayer, Felix P; Schmid, Diethart; Owens, W Anthony et al. (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408-2417
Quick, Matthias; Abramyan, Ara M; Wiriyasermkul, Pattama et al. (2018) The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites. Proc Natl Acad Sci U S A 115:E7924-E7931
Herborg, Freja; Andreassen, Thorvald F; Berlin, Frida et al. (2018) Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. J Biol Chem 293:7250-7262
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2018) How structural elements evolving from bacterial to human SLC6 transporters enabled new functional properties. BMC Biol 16:31
Doktorova, Milka; Weinstein, Harel (2018) Accurate In Silico Modeling of Asymmetric Bilayers Based on Biophysical Principles. Biophys J 115:1638-1643
LeVine, Michael V; Cuendet, Michel A; Razavi, Asghar M et al. (2018) Thermodynamic Coupling Function Analysis of Allosteric Mechanisms in the Human Dopamine Transporter. Biophys J 114:10-14
Stolzenberg, Sebastian; Li, Zheng; Quick, Matthias et al. (2017) The role of transmembrane segment 5 (TM5) in Na2 release and the conformational transition of neurotransmitter:sodium symporters toward the inward-open state. J Biol Chem 292:7372-7384
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2017) A Markov State-based Quantitative Kinetic Model of Sodium Release from the Dopamine Transporter. Sci Rep 7:40076
Sahai, Michelle A; Davidson, Colin; Khelashvili, George et al. (2017) Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB. Prog Neuropsychopharmacol Biol Psychiatry 75:1-9
Gregorio, G Glenn; Masureel, Matthieu; Hilger, Daniel et al. (2017) Single-molecule analysis of ligand efficacy in ?2AR-G-protein activation. Nature 547:68-73

Showing the most recent 10 out of 146 publications